Exane Derivatives’s Rayonier RYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-69
Closed -$1.99K 707
2019
Q1
$1.99K Buy
69
+8
+13% +$213 ﹤0.01% 448
2018
Q4
$1.52K Hold
61
﹤0.01% 543
2018
Q3
$1.85K Buy
61
+7
+13% +$224 ﹤0.01% 501
2018
Q2
$1.9K Sell
54
-9
-14% -$308 ﹤0.01% 501
2018
Q1
$2.02K Sell
63
-5
-7% -$152 ﹤0.01% 447
2017
Q4
$1.96K Sell
68
-249
-79% -$6.92K ﹤0.01% 462
2017
Q3
$8.32K Sell
317
-6
-2% -$156 ﹤0.01% 410
2017
Q2
$8.43K Buy
+323
New +$8.32K ﹤0.01% 407
2017
Q1
Sell
-339
Closed -$8.19K 667
2016
Q4
$8.19K Sell
339
-32
-9% -$774 ﹤0.01% 413
2016
Q3
$8.94K Sell
371
-7
-2% -$171 ﹤0.01% 412
2016
Q2
$9K Buy
378
+12
+3% +$275 ﹤0.01% 376
2016
Q1
$8.19K Hold
366
﹤0.01% 424
2015
Q4
$7.37K Hold
366
﹤0.01% 351
2015
Q3
$7.33K Buy
366
+38
+12% +$822 ﹤0.01% 371
2015
Q2
$7.61K Hold
328
﹤0.01% 375
2015
Q1
$8.03K Sell
328
-543
-62% -$13.8K ﹤0.01% 391
2014
Q4
$22.1K Buy
+871
New +$23.4K ﹤0.01% 383

Other funds holding RYN

Exane Derivatives's RYN Position: Q2 2019 in Review

Exane Derivatives sold out of Rayonier (RYN) in Q2 2019, closing a stake of 69 shares — an estimated $1.99K sold.

Exane Derivatives first reported a position in RYN in Q4 2014 and held it in 17 quarters. The position peaked at $22.1K in Q4 2014. 295 funds tracked by Wall St. Rank hold RYN as of Q2 2019.

  • Exane Derivatives reported no remaining Rayonier position as of Q2 2019 after selling out during the quarter.
  • Exane Derivatives sold 69 Rayonier shares in Q2 2019, an estimated $1.99K.
  • Exane Derivatives first reported a position in Rayonier in Q4 2014 and held it in 17 quarters.
  • Exane Derivatives's Rayonier position peaked at $22.1K in Q4 2014.
  • 295 funds tracked by Wall St. Rank held Rayonier as of Q2 2019.

Based on Exane Derivatives's 13F filing for Q2 2019, filed 12 Jul 2019.